Close
Patheon
Phase Appropriate Formulation Process Design
Product Development
Author: Anil Kane, Ph.D., MBA
Tuesday, February 07, 2017

Pharmaceutical companies walk a tightrope in early drug development. They have to balance speed, quality, scientific risk, and API cost. Compromising on any one of these four crucial elements can prove fatal to a product candidate. Appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development. 

 

Please complete the short form below to download this whitepaper.

Connect

We look forward to learning about your specific needs, please contact us.